The trend of ASDR for hypertension-related AA in global age groups from 2022 to 2050 predicted using the Bayesian age-period-cohort (BAPC) model. by Guanghui Yu (423945)

Comparison of circulating biomarkers among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds Ratio of multivariable analysis of factors for <i>Campylobacter species.</i> by Amete Mihret Teshale (12072758)

Comparison of HIV-DNA and cell-associated HIV-RNA levels among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds ratio of multivariable analysis of factors for non-typhoidal <i>Salmonella.</i> by Amete Mihret Teshale (12072758)

Trial sequential analysis of primary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Trial sequential analysis of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Mean age of patients submitting stool samples per study site. by Amete Mihret Teshale (12072758)

Odds ratio of multivariable analysis of factors for Shiga toxin-producing <i>Escherichia coli</i> (<i>stx</i> only). by Amete Mihret Teshale (12072758)

Comparison of immune and cellular markers of aging among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds ratio of multivariable analysis of factors for Shiga-toxin producing <i>Escherichia coli</i> (<i>stx</i> by Amete Mihret Teshale (12072758)

NS delays the formation of atherosclerotic plaques in ApoE^-/- mouse models. by Yihua Wang (491766)

NS attenuates ox-LDL-induced foam cell formation. by Yihua Wang (491766)

Schematic pathogenetic pathway of how persistent HIV reservoir may lead to premature aging and precocious onset of aging-related comorbidities. by Maria Raffaella Petrara (4446358)

(A) Time taken to reach platform in hidden trail, (B) Time taken to reach platform in visible trail, (C) Latency time to reach platform zone and (D) Time spent in platform zone in... by Hammad Ismail (4227988)

NS restores macrophage autophagy and alleviates the progression of atherosclerosis by inhibiting the PI3K/Akt/mTOR pathway. by Yihua Wang (491766)

Calibration of standards. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Appearance of standards under UV 365 nm. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

HPLC-Chromatogram of methanol fraction. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on kidney profile test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”